Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in ewing sarcoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacologic inhibition of epigenetic modification reveals targets of aberrant promoter methylation in ewing sarcoma
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 60, Issue 9, Pages 1437-1446
Publisher
Wiley
Online
2013-03-18
DOI
10.1002/pbc.24526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A microarray-based DNA methylation study of glioblastoma multiforme
- (2014) Ramon Martinez et al. Epigenetics
- Molecular Pathogenesis of Ewing Sarcoma: New Therapeutic and Transcriptional Targets
- (2011) Stephen L. Lessnick et al. Annual Review of Pathology-Mechanisms of Disease
- Mest/Peg1 inhibits Wnt signalling through regulation of LRP6 glycosylation
- (2011) Hwajin Jung et al. BIOCHEMICAL JOURNAL
- ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study
- (2011) Qiu-li Li et al. MEDICAL ONCOLOGY
- Effects of clusterin over-expression on metastatic progression and therapy in breast cancer
- (2010) Louise Flanagan et al. BMC CANCER
- A novel t(4;22)(q31;q12) produces an EWSR1–SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor
- (2010) Janos Sumegi et al. MODERN PATHOLOGY
- Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma
- (2009) K Revill et al. ENDOCRINE-RELATED CANCER
- Identification of a novel human cancer/testis gene MAEL that is regulated by DNA methylation
- (2009) Ling Xiao et al. MOLECULAR BIOLOGY REPORTS
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Aberrant methylation and reduced expression ofRASSF1Ain Ewing sarcoma
- (2009) Smadar Avigad et al. PEDIATRIC BLOOD & CANCER
- Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells
- (2008) Annie Hurtubise et al. Cancer Cell International
- Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma
- (2008) Yi Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Clusterin is epigenetically regulated in prostate cancer
- (2008) Hanna E. Rauhala et al. INTERNATIONAL JOURNAL OF CANCER
- Genome-Wide Analysis in a Murine Dnmt1 Knockdown Model Identifies Epigenetically Silenced Genes in Primary Human Pituitary Tumors
- (2008) K. J. Dudley et al. MOLECULAR CANCER RESEARCH
- Inhibition of NF-κB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis
- (2007) O. Takase et al. KIDNEY INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started